Market Overview:
The global acute lung injury market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of acute lung injuries, rising awareness about the treatment and diagnosis of acute lung injuries, and technological advancements in the field of diagnostics and therapeutics. The global acute lung injury market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into pharmacotherapy, mechanical ventilation, adjunctive procedures, fluid management, and others. On the basis of application, the market is segmented into hospitals, clinics,,and others. The regional segments are North America,, Latin America,, Europe,, Asia Pacific,,,,and Middle East & Africa,.
Product Definition:
Acute Lung Injury (ALI) is defined as a serious, and often life-threatening, problem that can occur when the lungs are injured. The most common cause of ALI is pneumonia, but other causes include: sepsis (a serious infection), near drowning, major trauma, and aspiration of vomit or food. Symptoms of ALI include shortness of breath, rapid breathing (tachypnea), coughing up blood (hemoptysis), chest pain, and fever. The importance of ALI lies in its ability to rapidly lead to respiratory failure and death if not treated aggressively.
Pharmacotherapy:
Pharmacotherapy is the use of drugs to treat a medical condition. In acute lung injury (ALI), there is a need for pharmacological treatment with the aim to improve lung function and reduce inflammation. The major driver for this market is increasing prevalence of ALI due to rising pollution levels, smoking habits, unhealthy diet and lack of physical activity which leads to various chronic diseases such as diabetes mellitus & cardiovascular disorders.
Mechanical Ventilation:
Mechanical ventilation is a process of providing respiratory support with or without the help of an artificial airway. It is used in cases where the patient has stopped breathing and requires emergency support. The most common cause for this condition is cardiac arrest, but it can also be caused by trauma, aspiration, drug/alcohol overdose as well as asthma attack.
The global mechanical ventilation and acute lung injury market size was valued at USD 3 billion in 2015.
Application Insights:
The others segment held the largest share of the global acute lung injury market in 2017. This segment includes mechanical ventilation, fluid management, and adjunct procedures. The use of pharmacological agents for the treatment of A/LI is limited to clinical trials and hence this approach is not commonly used across hospitals and clinics. Hence, other than hospital-based settings such as ICUs, A/LIs are treated only through an emergency department setting or a surgical intensive care unit (SICU).
In addition to this, there are certain conditions that require a longer period of hospitalization such as severe pneumonia or respiratory failure secondary to sepsis with multiple organ failures which requires admission in an ICU for further care and monitoring. Henceforth, these types of injuries attract high demand from both hospitals & clinics as well as other healthcare facilities resulting in higher revenue generation opportunities for market players catering to this application segment over others globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high healthcare expenditure and availability of advanced technologies for acute lung injury treatment. In addition, favorable reimbursement policies are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure and increasing patient awareness about acute lung injuries treatment options in this region.
In 2016, China emerged as a major medical tourist destination with more than 13 million tourists spending around USD X billion on health related services creating numerous opportunities for key players operating in this space (Hospitals/Clinics).
Growth Factors:
- Increasing incidence of respiratory diseases and disorders
- Rising awareness about acute lung injury and its symptoms
- Growing number of research and development activities for the treatment of acute lung injury
- Technological advancements in the diagnosis and treatment of acute lung injury
- increasing prevalence of smoking and air pollution
Scope Of The Report
Report Attributes
Report Details
Report Title
Acute Lung Injury Market Research Report
By Type
Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, Others
By Application
Hospitals, Clinics, Others
By Companies
Altor BioScience, FirstString Research, GlaxoSmithKline, Forschung und Entwicklung, Commence Bio, CompleGen, Histocell S.L., Stemedica Cell Technologies, Windtree Therapeutics, S-Evans Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Acute Lung Injury Market Report Segments:
The global Acute Lung Injury market is segmented on the basis of:
Types
Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Altor BioScience
- FirstString Research
- GlaxoSmithKline
- Forschung und Entwicklung
- Commence Bio
- CompleGen
- Histocell S.L.
- Stemedica Cell Technologies
- Windtree Therapeutics
- S-Evans Biosciences
Highlights of The Acute Lung Injury Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmacotherapy
- Mechanical Ventilation
- Adjunctive Procedures
- Fluid Management
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acute Lung Injury Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acute lung injury (ALI) is a serious condition that can occur when the air sacs in your lungs become inflamed. This can happen when you breathe in smoke, dust, or other particles from an accident or if you have a viral infection like the common cold.
Some of the major companies in the acute lung injury market are Altor BioScience, FirstString Research, GlaxoSmithKline, Forschung und Entwicklung, Commence Bio, CompleGen, Histocell S.L., Stemedica Cell Technologies, Windtree Therapeutics, S-Evans Biosciences.
The acute lung injury market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acute Lung Injury Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acute Lung Injury Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acute Lung Injury Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acute Lung Injury Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acute Lung Injury Market Size & Forecast, 2020-2028
4.5.1 Acute Lung Injury Market Size and Y-o-Y Growth
4.5.2 Acute Lung Injury Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pharmacotherapy
5.2.2 Mechanical Ventilation
5.2.3 Adjunctive Procedures
5.2.4 Fluid Management
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acute Lung Injury Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acute Lung Injury Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pharmacotherapy
9.6.2 Mechanical Ventilation
9.6.3 Adjunctive Procedures
9.6.4 Fluid Management
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pharmacotherapy
10.6.2 Mechanical Ventilation
10.6.3 Adjunctive Procedures
10.6.4 Fluid Management
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pharmacotherapy
11.6.2 Mechanical Ventilation
11.6.3 Adjunctive Procedures
11.6.4 Fluid Management
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pharmacotherapy
12.6.2 Mechanical Ventilation
12.6.3 Adjunctive Procedures
12.6.4 Fluid Management
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pharmacotherapy
13.6.2 Mechanical Ventilation
13.6.3 Adjunctive Procedures
13.6.4 Fluid Management
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acute Lung Injury Market: Competitive Dashboard
14.2 Global Acute Lung Injury Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Altor BioScience
14.3.2 FirstString Research
14.3.3 GlaxoSmithKline
14.3.4 Forschung und Entwicklung
14.3.5 Commence Bio
14.3.6 CompleGen
14.3.7 Histocell S.L.
14.3.8 Stemedica Cell Technologies
14.3.9 Windtree Therapeutics
14.3.10 S-Evans Biosciences
